These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 1704843
1. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats. Wiley JM, Yeager AM. Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843 [Abstract] [Full Text] [Related]
2. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays. Stiff PJ, Koester AR. Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881 [Abstract] [Full Text] [Related]
3. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays. Jones RJ, Colvin OM, Sensenbrenner LL. Cancer Res; 1988 Jun 15; 48(12):3394-7. PubMed ID: 3285994 [Abstract] [Full Text] [Related]
4. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V. Exp Hematol; 1992 Mar 15; 20(3):328-33. PubMed ID: 1568448 [Abstract] [Full Text] [Related]
5. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow. Mumcuoglu M, Naparstek E, Slavin S. Bone Marrow Transplant; 1990 Mar 15; 5(3):153-8. PubMed ID: 2184907 [Abstract] [Full Text] [Related]
6. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice. Pruijt JF, Lindley IJ, Heemskerk DP, Willemze R, Fibbe WE. Stem Cells; 1997 Mar 15; 15(1):50-5. PubMed ID: 9007222 [Abstract] [Full Text] [Related]
8. A subline of the Brown Norway myeloid leukemia in the Lewis x Brown Norway rat: in vivo growth characteristics and development of an in vitro clonogenic assay. Wiley JM, Yeager AM, Johnson RJ, Lanotte M. Int J Cell Cloning; 1989 Sep 15; 7(5):292-302. PubMed ID: 2788672 [Abstract] [Full Text] [Related]
9. In vitro evaluation of combination drug purging for autologous bone marrow transplantation. Jones RJ, Miller CB, Zehnbauer BA, Rowley SD, Colvin OM, Sensenbrenner LL. Bone Marrow Transplant; 1990 May 15; 5(5):301-7. PubMed ID: 2350626 [Abstract] [Full Text] [Related]
10. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A, Stachowiak J, Giarratana MC, Baillou C, Salmon C. Exp Hematol; 1986 Jun 15; 14(5):358-65. PubMed ID: 3519263 [Abstract] [Full Text] [Related]
12. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study. Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S. Bone Marrow Transplant; 1999 Feb 15; 23(3):235-41. PubMed ID: 10084254 [Abstract] [Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
14. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment. Straetmans N, Ma DD, Herman P, Zenebergh A, Chang A, Deneys V, De Bruyère M, Ferrant A. Bone Marrow Transplant; 1995 Mar 15; 15(3):421-8. PubMed ID: 7599567 [Abstract] [Full Text] [Related]
15. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model. Kühl JS, Sikic BI, Blume KG, Chao NJ. Exp Hematol; 1992 Oct 15; 20(9):1048-54. PubMed ID: 1468539 [Abstract] [Full Text] [Related]
16. Photoradiation methods for purging autologous bone marrow grafts. Gulati S, Atzpodien J, Lemoli RM, Shimazaki C, Clarkson B. Prog Clin Biol Res; 1990 Oct 15; 333():87-102. PubMed ID: 2137934 [Abstract] [Full Text] [Related]
17. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation. Brandwein JM, Nayar R, Baker MA, Sutton DM, Scott JG, Sutcliffe SB, Keating A. Exp Hematol; 1991 Mar 15; 19(3):191-5. PubMed ID: 1995310 [Abstract] [Full Text] [Related]
18. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A. Exp Hematol; 1993 Mar 15; 21(3):405-410. PubMed ID: 8440338 [Abstract] [Full Text] [Related]
19. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture. Grant S, Bhalla K, Arlin Z, Howe CW. Exp Hematol; 1990 Jan 15; 18(1):41-8. PubMed ID: 2298268 [Abstract] [Full Text] [Related]